Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Lanthionine Ketimine Ethyl Ester Accelerates Remyelination in a Mouse Model of Multiple Sclerosis
ASN Neuro ( IF 4.7 ) Pub Date : 2022-07-06 , DOI: 10.1177/17590914221112352 Jeffrey L Dupree 1, 2 , Pablo M Paez 3 , Seema K Tiwari-Woodruff 4 , Travis T Denton 5, 6, 7 , Kenneth Hensley 8 , Christina G Angeliu 3 , Anne I Boullerne 9 , Sergey Kalinin 9 , Sophia Egge 1 , Veronica T Cheli 3 , Giancarlo Denaroso 3 , Kelley C Atkinson 4 , Micah Feri 4 , Douglas L Feinstein 9, 10
ASN Neuro ( IF 4.7 ) Pub Date : 2022-07-06 , DOI: 10.1177/17590914221112352 Jeffrey L Dupree 1, 2 , Pablo M Paez 3 , Seema K Tiwari-Woodruff 4 , Travis T Denton 5, 6, 7 , Kenneth Hensley 8 , Christina G Angeliu 3 , Anne I Boullerne 9 , Sergey Kalinin 9 , Sophia Egge 1 , Veronica T Cheli 3 , Giancarlo Denaroso 3 , Kelley C Atkinson 4 , Micah Feri 4 , Douglas L Feinstein 9, 10
Affiliation
Although over 20 disease modifying therapies are approved to treat Multiple Sclerosis (MS), these do not increase remyelination of demyelinated axons or mitigate axon damage. Previous studies showe...
中文翻译:
羊毛硫氨酸酮亚胺乙酯加速多发性硬化小鼠模型的髓鞘再生
尽管超过 20 种疾病改良疗法被批准用于治疗多发性硬化症 (MS),但这些疗法不会增加脱髓鞘轴突的髓鞘再生或减轻轴突损伤。以前的研究表明...
更新日期:2022-07-06
中文翻译:
羊毛硫氨酸酮亚胺乙酯加速多发性硬化小鼠模型的髓鞘再生
尽管超过 20 种疾病改良疗法被批准用于治疗多发性硬化症 (MS),但这些疗法不会增加脱髓鞘轴突的髓鞘再生或减轻轴突损伤。以前的研究表明...